IP Verse

Wuesthoff & Wuesthoff Patentanwalte Partg Mbb opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Wuesthoff & Wuesthoff Patentanwalte Partg Mbb

Patent Number:
EP2967015
Title:
Transgenic Mice Expressing Chimeric Major Histocompatibility Complex (Mhc) Class Ii Molecules
Applicant:
REGENERON PHARMACEUTICALS, INC.
Opposition Date:
Mar 5, 2024
Patent Number:
EP2508188
Title:
Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol Hydrate
Applicant:
ASTRAZENECA AB
Opposition Date:
Feb 6, 2024
Patent Number:
EP3363811
Title:
Method For Producing Fusion Protein Having Igg Fc Domain
Applicant:
ALTEOGEN INC.
Opposition Date:
Jan 17, 2024
Patent Number:
EP3463180
Title:
Apparatus And Methods For Receiving Discharged Urine
Applicant:
FOREHAND, JOSEPH M.
Opposition Date:
Dec 29, 2023
Patent Number:
EP3067043
Title:
Pharmaceutical Compositions Based On Superstructures Of Angiotensin Receptor Antagonist/Blocker (Arb) And Neutral Endopeptidase (Nep) Inhibitor
Applicant:
NOVARTIS AG
Opposition Date:
Aug 16, 2023
Patent Number:
EP3199952
Title:
Method For Measuring Reactivity Of Fviii
Applicant:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Opposition Date:
Jul 26, 2023
Patent Number:
EP2247751
Title:
Disease Resistant Pepper Plants
Applicant:
HAZERA GENETICS LTD.
Opposition Date:
Jul 5, 2023
Patent Number:
EP2959894
Title:
S1P Receptor Modulators For Treating Multiple Sclerosis
Applicant:
NOVARTIS AG
Opposition Date:
May 10, 2023
Patent Number:
EP3716992
Title:
Use Of A Vegf Antagonist To Treat Angiogenic Eye Disorders
Applicant:
REGENERON PHARMACEUTICALS, INC.
Opposition Date:
May 5, 2023
Patent Number:
EP3265122
Title:
Combination Of A Pd-1 Antagonist And Eribulin For Treating Cancer
Applicant:
EISAI R&D MANAGEMENT CO., LTD.
Opposition Date:
Jan 18, 2023

Competitors of Wuesthoff & Wuesthoff Patentanwalte Partg Mbb

NOVARTIS AG

REGENERON PHARMACEUTICALS, INC.

CITY OF HOPE

Want to track Wuesthoff & Wuesthoff Patentanwalte Partg Mbb?

Feel free to send us a message here and we will get back to you